CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...

The Iowa House approved a bill Monday evening that would place limits on pharmacy benefit managers, the companies that ...

NEW YORK (Reuters) -President Donald Trump on Monday delivered a blow to the private-sector middlemen who negotiate U.S. drug ...

The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...

The court found that the League of United Latin American Citizens of Iowa lacked standing to bring its lawsuit challenging ...

A measure now on the floor of the Nebraska Legislature would address some practices by intermediaries called pharmacy benefit managers that pharmacists say are harming their businesses.

Novo Nordisk has potential with a 27% upside, strong market shares, and high ROI strategies. See why we recommend a buy on ...

The blow came from the highest levels of government, spooking investors and driving down the stock prices of numerous ...

President Trump's new Executive Order aims to lower prescription drug prices by tying U.S. costs to global rates. Read more ...